PROTO LABS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.9 USD | -0.61% |
|
+2.41% | -18.07% |
| Feb. 12 | Craig-Hallum Adjusts Proto Labs Price Target to $38 From $30, Maintains Hold Rating | MT |
| Feb. 09 | Transcript : Proto Labs, Inc., Q4 2023 Earnings Call, Feb 09, 2024 |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the past twelve months, EPS forecast has been revised upwards.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company sustains low margins.
- With an expected P/E ratio at 33.21 and 28.66 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Industrial Machinery & Equipment
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -18.07% | 820M | C | ||
| +11.18% | 76.6B | A- | ||
| +17.39% | 70.68B | B | ||
| +17.86% | 36.54B | B- | ||
| +13.47% | 31.6B | A | ||
| +3.37% | 28.41B | C+ | ||
| +11.24% | 26.88B | B- | ||
| +4.68% | 26.57B | B+ | ||
| +14.67% | 24.58B | B+ | ||
| +11.31% | 23.67B | B |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- PRLB Stock
- Ratings Proto Labs, Inc.
